musheng bao
Harbour Antibodies US/Harbour BioMed
Natick, MA, United States
Review Editor
Cancer Immunity and Immunotherapy
Harbour Antibodies US/Harbour BioMed
Natick, MA, United States
Review Editor
Cancer Immunity and Immunotherapy
University of California, San Francisco
San Francisco, United States
Review Editor
Cancer Immunity and Immunotherapy
Jagiellonian University Medical College
Kraków, Poland
Review Editor
Cancer Immunity and Immunotherapy
Department of Leukemia, University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy
Longwood University
Farmville, United States
Review Editor
Cancer Immunity and Immunotherapy
California Lutheran University
Thousand Oaks, United States
Review Editor
Cancer Immunity and Immunotherapy
G. Pascale National Cancer Institute Foundation (IRCCS)
Naples, Italy
Review Editor
Cancer Immunity and Immunotherapy
University of São Paulo
São Paulo, Brazil
Review Editor
Cancer Immunity and Immunotherapy
Massachusetts General Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Immunity and Immunotherapy
Ospedale San Bortolo
Vicenza, Italy
Review Editor
Cancer Immunity and Immunotherapy
Department of Developmental and Stem Cell Biology, Beckman Research Institute, City of Hope
City of Hope, United States
Review Editor
Cancer Immunity and Immunotherapy
Duke University Medical Center, Duke University
Durham, United States
Review Editor
Cancer Immunity and Immunotherapy
GamaMabs Pharma
Toulouse, France
Review Editor
Cancer Immunity and Immunotherapy
Fundación Cáncer
Buenos Aires, Argentina
Review Editor
Cancer Immunity and Immunotherapy
Institute of Cancer of São Paulo, Faculty of Medicine, University of São Paulo
São Paulo, Brazil
Review Editor
Cancer Immunity and Immunotherapy
The University of Melbourne
Parkville, Australia
Review Editor
Cancer Immunity and Immunotherapy